Canada Pension Plan Investment Board
SGMT icon

Canada Pension Plan Investment Board’s Sagimet Biosciences SGMT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Buy
40,200
+27,700
+222% +$188K ﹤0.01% 1440
2026
Q1 		$65.3K Buy
+12,500
New +$69.7K ﹤0.01% 1667

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Canada Pension Plan Investment Board's SGMT Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Sagimet Biosciences (SGMT) stake by 222% in Q2 2026, buying an estimated $188K and bringing the position to 40,200 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #1440.

Canada Pension Plan Investment Board first reported a position in SGMT in Q1 2026 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Canada Pension Plan Investment Board held 40,200 shares of Sagimet Biosciences worth $311K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 27,700 Sagimet Biosciences shares in Q2 2026, an estimated $188K.
  • Sagimet Biosciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1440 holding.
  • Canada Pension Plan Investment Board first reported a position in Sagimet Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.